SENECA THERAPEUTICS
Seneca is a biotechnology company that focuses on developing novel oncolytic immunotherapeutics and derivatives as cancer therapeutics, cancer vaccines, and vaccines for the treatment of cancer. This oncolytic immunotherapeutic is called Seneca Valley Virus (SVV) which eliminates tumor cells in which it can replicate. Seneca Therapeutics is headquartered in Blue Bell, Pennsylvania.
SENECA THERAPEUTICS
Social Links:
Industry:
Biopharma Biotechnology Life Science Pharmaceutical
Founded:
2018-01-01
Address:
Blue Bell, Pennsylvania, United States
Country:
United States
Website Url:
http://www.senecatherapeutics.com
Status:
Active
Contact:
484-883-9725
Total Funding:
0
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Content Delivery Network Microsoft Exchange Online Organization Schema Microsoft Azure DNS
Similar Organizations
Biopep Solutions
Biopep Solutions is a biotechnology company that discovers and develops therapeutic products for the treatment of cancer and other diseases.
Netnoids Rx Laboratories
Netnoids Rx Laboratories uses patient-derived organoid model systems to help find a cure for rare cancers.
SciSafe
SciSafe is a biotechnology company that offers dedicated pharmaceutical and biological specimen storage in its state of the art facility.
Current Employees Featured
Founder
Investors List
Mid Atlantic Bio Angels
Mid Atlantic Bio Angels investment in Venture Round - Seneca Therapeutics
Broad Street Angels
Broad Street Angels investment in Venture Round - Seneca Therapeutics
Official Site Inspections
http://www.senecatherapeutics.com Semrush global rank: 6.57 M Semrush visits lastest month: 954
- Host name: 198.49.23.145
- IP address: 198.49.23.145
- Location: New York United States
- Latitude: 40.7157
- Longitude: -74
- Metro Code: 501
- Timezone: America/New_York
- Postal: 10013
More informations about "Seneca Therapeutics"
Our Team - Seneca Therapeutics Therapeutics
Prior to joining Seneca Therapeutics, Dr. Trinh was a consultant to the Department of U.S. Defense, WRAIR, and non-profit organization Henry M. Jackson Foundation to lead viral and โฆSee details»
Seneca Therapeutics - Crunchbase Company Profile
Seneca is a biotechnology company that focuses on developing novel oncolytic immunotherapeutics for the treatment of cancer.See details»
Seneca Therapeutics, Inc. Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Seneca Therapeutics, Inc. of Blue Bell, PA. Get the latest business insights from Dun & Bradstreet.See details»
Seneca Therapeutics, Inc. | LinkedIn
Seneca Therapeutics, Inc. Biotechnology Research Philadelphia, PA 483 followers Seneca Therapeutics is developing a novel cancer therapy (oncolytic immunotherapeutic) for patients with solid cancersSee details»
Seneca Therapeutics - Org Chart, Teams, Culture & Jobs - The Org
View Seneca Therapeutics' up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more.See details»
Home โ Seneca Therapeutics Therapeutics
We believe a cure for cancer is within our lifetime and we are working with urgency to see this promising possibility become a reality. learn more ๏ปฟ๏ปฟSee details»
Seneca Therapeutics - PitchBook
Seneca Therapeutics General Information Description. Developer of cell-based therapies designed to offer therapeutics and vaccines for solid cancer. The company focuses on oncolytic immunotherapeutic candidates to synergize โฆSee details»
Seneca Therapeutics, Inc. | Life Sciences PA
Www.senecatherapeutics.com; About. Seneca Therapeutics, Inc. (Seneca) is pursuing the development of an oncolytic immunotherapeutic called Seneca Valley Virus (SVV) and โฆSee details»
Seneca Therapeutics - Products, Competitors, Financials, โฆ
Senecatherapeutics.com. Overview & Products; Financials; People; Founded Year 2018. Stage Debt - IV | Alive. Total Raised $6.45M. Last Raised $5M | 4 yrs ago. About Seneca โฆSee details»
Seneca Therapeutics, Inc. | BioPharm America - Informa Connect
Seneca Therapeutics, Inc. (STI) was founded to develop the novel, clinically tested oncolytic Seneca Valley Virus (SVV) based on two key value drivers.See details»
Seneca Therapeutics, Inc. - Drug pipelines, Patents, Clinical
Seneca Therapeutics undertakes no obligation to update any forward-looking statements for any reason. www.senecatherapeutics.com. ... The statistics for drugs in the Pipeline is the current โฆSee details»
Our Mission โ Seneca Therapeutics Therapeutics
Seneca Therapeutics, Inc. (Seneca) is developing a pipeline of novel cancer agents using the nonpathogenic Seneca Valley Virus isolate 001 (SVV-001).See details»
Seneca Therapeutics - VentureRadar
Auto Analyst Score: 37 | senecatherapeutics.com. VentureRadar Popularity. Medium. VentureRadar Popularity: Medium. The popularity score combines profile views, clicks and the โฆSee details»
SVV-044 - Drug Targets, Indications, Patents - Synapse - Patsnap
Originator Organization. Seneca Therapeutics, Inc. Startup. Active Organization. Seneca Therapeutics, Inc. Startup. Inactive Organization-Drug ... Contacts Paul Hallenbeck โฆSee details»
Seneca Therapeutics Receives FDA Clearance to Begin SVV-001 โฆ
Oct 3, 2022 Paul Hallenbeck CSO and President [email protected]. James Hussey CEO [email protected]. www.senecatherapeutics.com. Contacts.See details»
Seneca Therapeutics โ VisionTech Partners
Seneca Therapeutics is developing a pipeline of novel cancer agents using the nonpathogenic Seneca Valley Virus isolate 001 (SVV-001). The first product anticipated to be in later stage โฆSee details»
Seneca Therapeutics, Inc. Receives Positive Feedback from FDA on ...
Sep 14, 2020 PHILADELPHIA--(BUSINESS WIRE)--Seneca Therapeutics, Inc., a clinical-stage biopharmaceutical company dedicated to the development of oncolytic immunotherapeutics for โฆSee details»
Latest News โ Seneca Therapeutics Therapeutics
Nov 15, 2023 www.senecatherapeutics.com. Mason Duling. October 30, 2023. Seneca Therapeutics Garners Prestigious Recognition at Keiretsu Forumโs Investor Capital Expo. โฆSee details»
Eterna Therapeutics Changes Name to Ernexa Therapeutics to
1 day ago Ernexa Therapeutics embarks on new strategic direction, shifting the companyโs focus from delivering a cell therapy platform to prioritizing product developmentSee details»
Dr. Paul Hallenbeck, CSO and President of Seneca Therapeutics to ...
Nov 27, 2023 www.senecatherapeutics.com. Contacts. Paul Hallenbeck CSO and President [email protected]. James Hussey CEO โฆSee details»